Finance

Beta
Lists
ACHV:NASDAQ
Achieve Life Sciences Inc
6,40 US$
-1,99%
(-0,13) 1D
6,40 US$
+0,04% (+0,0027)
After hours
Closed: 1 ივლ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACHV...
Open
6,49 US$
High
7,11 US$
Low
6,27 US$
Mkt. cap
657,02 მლნ.
Avg. vol.
2,22 მლნ.
Volume
53,00
52-wk high
7,11 US$
52-wk low
2,02 US$
EPS
-1,11 US$
Beta
2,27
Shares outstanding
102,66 მლნ.
No. of employees
28
Open
6,49 US$
High
7,11 US$
Low
6,27 US$
Mkt. cap
657,02 მლნ.
Avg. vol.
2,22 მლნ.
Volume
53,00
52-wk high
7,11 US$
52-wk low
2,02 US$
EPS
-1,11 US$
Beta
2,27
Shares outstanding
102,66 მლნ.
No. of employees
28
News stories
From sources across the web
About Achieve Life Sciences Inc
CEO-
Employees28
Founded1991
Headquartersსიეტლი, ვაშინგტონის შტატი, ამერიკის შეერთებული შტატები
Sector-
Websiteachievelifesciences.com
Analyst ratings
Based on 6 analysts giving stock ratings to ACHV in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ACHV in the last 3 months.
Highest
Current 6,40 US$
20,00 US$ (+212,50%)
Average
14,33 US$ (+123,91%)
Lowest
10,00 US$ (+56,25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Deschner
Raymond James
Buy
Initiated
20,00 US$
+212,5%
06/26/2026
Jason McCarthy
Maxim Group
Buy
Maintained
10,00 US$
+56,2%
06/22/2026
Gary Nachman
Canaccord Genuity
Buy
Reiterated
13,00 US$
+103,1%
06/23/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
12,00 US$
+87,5%
06/23/2026
Mark Smith
Lake Street
Buy
Maintained
11,00 US$
+71,9%
05/13/2026
Justin Walsh
JonesTrading
Buy
Reiterated
20,00 US$
+212,5%
05/12/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
13,00 US$
+103,1%
04/20/2026
Thomas Flaten
Lake Street
Buy
Maintained
11,00 US$
+71,9%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6,71 მლნ.
5,32 მლნ.
3,87 მლნ.
3,29 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,86 მლნ.
9,37 მლნ.
10,86 მლნ.
7,17 მლნ.
Operating expense
12,56 მლნ.
14,69 მლნ.
14,73 მლნ.
10,46 მლნ.
Total operating expenses
12,56 მლნ.
14,69 მლნ.
14,73 მლნ.
10,46 მლნ.
Operating income
-12,56 მლნ.
-14,69 მლნ.
-14,73 მლნ.
-10,46 მლნ.
Other non operating income
-59,00 ათ.
-5,00 ათ.
7,00 ათ.
-13,00 ათ.
EBT including unusual items
-12,72 მლნ.
-14,44 მლნ.
-14,66 მლნ.
-10,17 მლნ.
EBT excluding unusual items
-12,62 მლნ.
-14,34 მლნ.
-14,55 მლნ.
-10,45 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12,72 მლნ.
-14,44 მლნ.
-14,66 მლნ.
-10,17 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,37
-0,28
-0,28
-0,19
Interest and investment income
192,00 ათ.
554,00 ათ.
427,00 ათ.
297,00 ათ.
Interest expense
-191,00 ათ.
-192,00 ათ.
-251,00 ათ.
-274,00 ათ.
Net interest expenses
1,00 ათ.
362,00 ათ.
176,00 ათ.
23,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-12,51 მლნ.
-14,64 მლნ.
-14,67 მლნ.
-10,41 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer